Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News

11:41 EST 14th December 2018 | BioPortfolio

Showing News Articles 1–25 of 440,000+

Friday 14th December 2018

Rusan Pharma launches DCGI approved Aposan to treat patients with Parkinson's disease

Rusan Pharma, a fully integrated global pharmaceutical company specializing in the treatment of 'Addiction and Pain Management', announced the launch of DCGI approved Aposan (apomorphine hydrochloride (HCl)

Sulfasalazine 500mg Ds Tablet

Sulfasalazine 500mg Ds Tablet

Orexo regains rights to Zubsolv in all countries outside US

Orexo AB, the fully integrated specialty pharmaceutical company addressing opioid addiction and pain, announces that the company will regain the rights to Zubsolv (buprenorphine and naloxone sublingual tablet)

Pulmonary Arterial Hypertension Global Clinical Trials Review, H1, 2018 [Report Updated: 29062018] Prices from USD $2125

Pulmonary Arterial Hypertension Global Clinical Trials Review, H1, 2018SummaryGlobalData's clinical trial report, Pulmonary Arterial Hypertension Global Clinical Trials Review, H1, 2018" provides an overview of Pulmonary Arterial Hypertension clinical trials scenario. This report provides top line data relating to the clinical trials on Pulmonary Arterial Hypertension. Report includes an overview ...

WellSky Expands Investment in Hospice Technology with Acquisition of Consolo Services Group

Acquisition strengthens WellSky’s hospice industry leadership and innovation, and incorporates solutions serving the palliative care, adult day care, and memory care markets WellSky, a leading health and community care technology company backed by TPG Capital, and

Evotec AG (EVT-DE): Innovating for the long term

goetzpartners securities Limited 14-Dec-2018 / 15:29 GMT/BST Free to access research and investor meetings in a post-MiFID2 world. This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail clien...

United Kingdom Sleep Apnea Diagnostic Systems Market Outlook to 2025 [Report Updated: 01102018] Prices from USD $4246

United Kingdom Sleep Apnea Diagnostic Systems Market Outlook to 2025SummaryGlobalData's new report, United Kingdom Sleep Apnea Diagnostic Systems Market Outlook to 2025, provides key market data on the United Kingdom Sleep Apnea Diagnostic Systems market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments Fixed Polysomnography Syste...

Costco’s Q1 earnings rise as construction in China progresses

Costco's earnings climbed more than 19% in the firs

Adhesives for Biomedical Applications Can be Detached With Light

NewsPulling off a Band-Aid may soon get a lot less painful.Contributed Author: Harvard Joh

Lakeview Farms acquires Tribe Mediterranean Foods

Lakeview Farm

CMS Consumer Survey Ranks Commonwealth Care Alliance®’s One Care as a Top Medicare-Medicaid Health Plan for Third Consecutive Year

Annual CAHPS nationwide survey asks consumers to rate health care experience, including quality and access Commonwealth Care Alliance’s (CCA) One Care plan received the nation’s highest rating in the 2018

Quantum Chemical Calculations on Quantum Computers

NewsA quantum algorithm capable of performing quantum circuits parallelism and full configuration interactions calculations in any open shell molecules without exponential/combinatorial explosion.

Systolic Hypertension Global Clinical Trials Review, H2, 2018 [Report Updated: 31082018] Prices from USD $2125

Systolic Hypertension Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Systolic Hypertension Global Clinical Trials Review, H2, 2018" provides an overview of Systolic Hypertension clinical trials scenario. This report provides top line data relating to the clinical trials on Systolic Hypertension. Report includes an overview of trial numbers and their average enrol...

Genetically Modified Pigs May Prevent Bacon Shortages

The meat and poultry industry is in need of novel methods to stave off infection. A group from the College of Animal Sciences, Jilin University in China has combined the gene-editing tool CRISPR-Cas9 with the gene expression silencing technique of RNA interference (RNAi), to develop genetically modified pigs that are protected from classical swine fever virus […] The post Genetically Modifi...

Human Sex Reversal Attributed to Gain or Loss of Regulatory DNA

When the development of the gonads or genitalia follows an alternative course, the result is sometimes called a disorder of sex development (DSD) or sex reversal. In either case, the anatomical or gonadal sex determination is poorly understood, even though a few gene variants have been identified that appear to lead to DSDs. Such variants […] The post Human Sex Reversal Attributed to Gain or...

Delayed-Phase MRI Accurate in Evaluating Residual Breast Tumor Size

Lobular or HER2–negative cancers are underestimated in size at MRI compared with ductal or other subtypes.

Weleda intros new Skin Food Experience additions

Researchers Design Technology That Sees Nerve Cells Fire

NewsResearchers at Stanford University have created a noninvasive technology that detects when nerve cells fire based on changes in shape. Cont

Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, ZIRABEV™ (bevacizumab)

ZIRABEV™ (bevacizumab), a potential biosimilar to Avastin®* (bevacizumab), is Pfizer’s second therapeutic oncology biosimilar to receive a positive CHMP opinion in Europe in 2018 Pfizer Inc. (NYSE:PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive...

Sliding into the weekend... #SnowBearspic.twitter.com/aKiOkpHgcA

Sliding into the weekend... #SnowBears pic.twitter.com/aKiOkpHgcA

China’s unique and complex history with AIDS involves a litany of scandals and government cover-ups that have left a lasting imprint of stigma and fear about HIV and AIDS — and discrimination. https://buff.ly/2ULLeyk 

China’s unique and complex history with AIDS involves a litany of scandals and government cover-ups that have left a lasting imprint of stigma and fear about HIV and AIDS — and discrimination. https://buff.ly/2ULLeyk 

EU5 Dental CAD/CAM Systems and Materials Market Outlook to 2025 [Report Updated: 01102018] Prices from USD $5096

EU5 Dental CAD/CAM Systems and Materials Market Outlook to 2025SummaryGlobalData's new report, EU5 Dental CAD/CAM Systems and Materials Market Outlook to 2025, provides key market data on the EU5 CAD/CAM Systems and Materials market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments CAD/CAM Materials Market and CAD/CAM Systems Mark...

Healogics, Inc. Names David Jollow as Chief Information Security Officer

Healogics, the nation’s largest provider of advanced chronic wound care services, today announced that it has appointed David Jollow to serve as Chief Information Security Officer. In this role, Jollow will conduct assessments of current IT security and risks, and provide next generation security solutions. He will also be responsible for enhancing, impl...

Mission Bio Raises $30M, Plans for Expansion into Gene Editing, Further Tapestri Platform Development

Mission Bio has completed a $30 million Series B financing, saying it plans to use the proceeds toward expanding and further developing its single-cell DNA genomics platform Tapestri® for oncology; broaden the scope of its activity into CRISPR and other gene editing applications; and expand overseas. Charlie Silver, Mission Bio co-founder and CEO, told GEN […] The post Mission Bio Raises $3...

MitraClip does not significantly improve outcomes in secondary mitral regurgitation: the MITRA-FR trial

1. Among patients with heart failure with reduced ejection fraction (HFrEF) and severe secondary mitral regurgitation on medical therapy, percutaneous mitral valve repair did not significantly reduce 12-month rates of death or hospitalization due to heart failure when compared to medical therapy alone. 2. Percutaneous mitral valve repair was associated with increased rates of stroke, […]


Advertisement
Quick Search
Advertisement
Advertisement

 

BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 275 sources.